Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Circulating microparticles as a predictor of vascular properties in patients on mechanical circulatory support; hype or hope

P. Ivak, J. Pitha, I. Netuka

. 2016 ; 65 (5) : 727-735. [pub] 20160715

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc17012783

Grantová podpora
NT14019 MZ0 CEP - Centrální evidence projektů

Microparticles are small circulating vesicles originating from circulatory system and vascular wall cells released during their activation or damage. They possess different roles in regulation of endothelial function, inflammation, thrombosis, angiogenesis, and in general, cellular stress. Microparticles are the subject of intensive research in pulmonary hypertension, atherosclerotic disease, and heart failure. Another recently emerging role is the evaluation of the status of vasculature in end-stage heart failure patients treated with implantable ventricular assist devices. In patients implanted as destination therapy, assessment of the long-term effect of currently used continuous-flow left ventricular assist devices (LVADs) on vasculature might be of critical importance. However, unique continuous flow pattern generated by LVADs makes it difficult to assess reliably the vascular function with most currently used methods, based mainly on ultrasound detection of changes of arterial dilatation during pulsatile flow. In this respect, the measurement of circulating microparticles as a marker of vascular status may help to elucidate both short- and long-term effects of LVADs on the vascular system. Because data regarding this topic are very limited, this review is focused on the advantages and caveats of the circulating microparticles as markers of vascular function in patients on continuous-flow LVADs.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17012783
003      
CZ-PrNML
005      
20190829144807.0
007      
ta
008      
170412s2016 xr f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.933246 $2 doi
035    __
$a (PubMed)27429109
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Ivak, P $u Department of Cardiovascular Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; 3rd Faculty of Medicine, Charles University, Prague, Czech Republic
245    10
$a Circulating microparticles as a predictor of vascular properties in patients on mechanical circulatory support; hype or hope / $c P. Ivak, J. Pitha, I. Netuka
520    9_
$a Microparticles are small circulating vesicles originating from circulatory system and vascular wall cells released during their activation or damage. They possess different roles in regulation of endothelial function, inflammation, thrombosis, angiogenesis, and in general, cellular stress. Microparticles are the subject of intensive research in pulmonary hypertension, atherosclerotic disease, and heart failure. Another recently emerging role is the evaluation of the status of vasculature in end-stage heart failure patients treated with implantable ventricular assist devices. In patients implanted as destination therapy, assessment of the long-term effect of currently used continuous-flow left ventricular assist devices (LVADs) on vasculature might be of critical importance. However, unique continuous flow pattern generated by LVADs makes it difficult to assess reliably the vascular function with most currently used methods, based mainly on ultrasound detection of changes of arterial dilatation during pulsatile flow. In this respect, the measurement of circulating microparticles as a marker of vascular status may help to elucidate both short- and long-term effects of LVADs on the vascular system. Because data regarding this topic are very limited, this review is focused on the advantages and caveats of the circulating microparticles as markers of vascular function in patients on continuous-flow LVADs.
650    _2
$a biologické markery $x krev $7 D015415
650    12
$a mikropartikule $7 D055252
650    _2
$a srdeční selhání $x terapie $7 D006333
650    _2
$a podpůrné srdeční systémy $x škodlivé účinky $7 D006353
650    _2
$a lidé $7 D006801
650    _2
$a nemoci cév $x diagnóza $x etiologie $7 D014652
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Piťha, Jan, $d 1964- $7 mzk2003187379 $u Laboratory for Atherosclerosis Research, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Netuka, Ivan, $d 1973- $7 xx0074183 $u Department of Cardiovascular Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; Second Department of Surgery, Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 65, č. 5 (2016), s. 727-735
856    41
$u http://www.biomed.cas.cz/physiolres/ $y domovská stránka časopisu
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20170412 $b ABA008
991    __
$a 20190829145031 $b ABA008
999    __
$a ok $b bmc $g 1201961 $s 973556
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 65 $c 5 $d 727-735 $e 20160715 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
GRA    __
$a NT14019 $p MZ0
LZP    __
$b NLK118 $a Pubmed-20170412

Najít záznam

Citační ukazatele

Možnosti archivace